SCYL1 Antibody
-
中文名稱：SCYL1兔多克隆抗體
-
貨號：CSB-PA839356DSR2HU
-
規(guī)格：￥440
-
圖片：
-
Western blot
All lanes: SCYL1 antibody at 3.15 μg/ml
Lane 1: 293T whole cell lysate
Lane 2: Hela whole cell lysate
Lane 3: 3T3 whole cell lysate
Lane 4: A549 whole cell lysate
Secondary
Goat polyclonal to rabbit IgG at 1/10000 dilution
Predicted band size: 90, 89, 79, 87, 70 kDa
Observed band size: 90, 110 kDa
-
-
其他：
產(chǎn)品詳情
-
產(chǎn)品名稱：Rabbit anti-Homo sapiens (Human) SCYL1 Polyclonal antibody
-
Uniprot No.：
-
基因名：SCYL1
-
別名：Coated vesicle associated kinase of 90 kDa antibody; Coated vesicle-associated kinase of 90 kDa antibody; CVAK90 antibody; GKLP antibody; HT019 antibody; Likely ortholog of mouse N terminal kinase like protein antibody; MGC78454 antibody; N terminal kinase like antibody; N terminal kinase like protein antibody; N-terminal kinase-like protein antibody; NKTL antibody; NTKL antibody; NTKL_HUMAN antibody; NTKLBP1 antibody; P105 antibody; SCY L1 antibody; SCY1 like 1 antibody; SCY1 like 1 protein 1 antibody; SCY1-like protein 1 antibody; SCYL 1 antibody; Scyl1 antibody; SCYL1BP1 antibody; TAPK antibody; TEIF antibody; Telomerase regulation associated protein antibody; Telomerase regulation-associated protein antibody; Telomerase transcriptional element interacting factor antibody; Telomerase transcriptional element-interacting factor antibody; Teratoma associated tyrosine kinase antibody; Teratoma-associated tyrosine kinase antibody; TRAP antibody
-
宿主：Rabbit
-
反應(yīng)種屬：Human
-
免疫原：Recombinant Human N-terminal kinase-like protein (460-740AA)
-
免疫原種屬：Homo sapiens (Human)
-
標(biāo)記方式：Non-conjugated
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：Antigen Affinity Purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
-
產(chǎn)品提供形式：Liquid
-
應(yīng)用范圍：ELISA, WB
-
推薦稀釋比：
Application Recommended Dilution WB 1:1000-1:5000 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產(chǎn)品評價
相關(guān)產(chǎn)品
靶點詳情
-
功能：Regulates COPI-mediated retrograde protein traffic at the interface between the Golgi apparatus and the endoplasmic reticulum. Involved in the maintenance of the Golgi apparatus morphology. Has no detectable kinase activity in vitro.; Isoform 6 acts as transcriptional activator. It binds to three different types of GC-rich DNA binding sites (box-A, -B and -C) in the beta-polymerase promoter region. It also binds to the TERT promoter region.
-
基因功能參考文獻：
- findings indicate that SCYL1 does not contribute to REST turnover and thus do not support a previous study suggesting a role for SCYL1 in mediating REST degradation PMID: 28570664
- Disruptive SCYL1 mutations underlie a syndrome characterized by recurrent episodes of liver failure, peripheral neuropathy, cerebellar atrophy, and ataxia. PMID: 26581903
- Data identified the large GTPase dynamin2 as an interacting protein of NTKL, which might be responsible for the phenotype alterations caused by NTKL overexpression, such as cytokinesis failure, increased cell motility and abnormal of cell division. PMID: 25575811
- Data reveal that Scyl1 is a key organizer of a subset of the COPI machinery. PMID: 24481816
- TEIF is a downstream effector in EGF/PI3K/Akt signaling. PMID: 24769208
- TEIF as a novel MSP58-interacting protein. PMID: 24361335
- suggested that the interaction of SCYL1BP1/Pirh2 could accelerate Pirh2 degradation through an ubiquitin-dependent pathway. SCYL1BP1 may function as an important tumor suppressor gene in HCC development PMID: 22570270
- TEIF protein and centrosome amplification is commonly found in colorectal tumors. The expression level of TEIF is related to tumor histological grade and malignant degree. PMID: 19958622
- Scyl1 interacts with 58K/formiminotransferase cyclodeaminase (FTCD) and golgin p115, and is required for the maintenance of Golgi morphology PMID: 20209057
- Scyl1 participates in the nuclear aminoacylation-dependent tRNA export pathway. PMID: 20505071
- SCYL1-BP1 can be ubiquitinated and degraded by Pirh2 but not by MDM2, which suggests that SCYL1-BP1 can be regulated by Pirh2. PMID: 20598683
- NTKL is involved in centrosome-related cellular functions PMID: 12036289
- Molecular cloning of telomerase transcriptional elements-interacting factor,(TEIF). TEIF may take part in the transcriptional activation of hTERT. PMID: 15504359
- TEIF could specifically activate transcription of beta-pol promoter, but not that of DNA polymerase alpha or delta promoter. The responsible sequences for binding of TEIF were revealed PMID: 15963946
- TEIF functions as a centrosome regulator. Its participation in DNA damage response, including telomere dysfunction and tumorigenesis. PMID: 19198626
顯示更多
收起更多
-
相關(guān)疾病：Spinocerebellar ataxia, autosomal recessive, 21 (SCAR21)
-
亞細胞定位：Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Endoplasmic reticulum-Golgi intermediate compartment. Golgi apparatus, cis-Golgi network. Note=Localized to the Endoplasmic reticulum-Golgi intermediate and cis-Golgi in an ARF1-independent manner.; [Isoform 1]: Cytoplasm. Note=Cytoplasmic throughout the cell cycle.; [Isoform 2]: Cytoplasm. Note=Cytoplasmic throughout the cell cycle.; [Isoform 3]: Cytoplasm. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Note=Cytoplasmic during interphase and centrosomal during mitosis, it localizes to the centrosomes in a microtubule-independent manner.; [Isoform 6]: Nucleus.
-
蛋白家族：Protein kinase superfamily
-
組織特異性：Ubiquitous.
-
數(shù)據(jù)庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
